About
About me.

I’m Jordan. My background is in nursing, and I’m pursuing my master’s to become a family nurse practitioner. My interests in metabolic health, endocrinology, and obesity medicine have drawn me toward the intersection of clinical practice, technology, and venture.
Working directly with people living with chronic disease has shaped how I think about innovation in healthcare. It has given me a view of the problems that exist beyond the research paper or product demo: where care is fragmented, where clinicians lack the right tools, where patients fall through the cracks, and where better technology could meaningfully change outcomes.
That perspective is what I hope to bring to technology and venture. I’m interested not only in what is technically possible, but in identifying where new capabilities can solve real healthcare problems—and helping bridge the gap between the people building those technologies and the clinicians and patients who ultimately have to use them.
At heart, I’m a techno-optimist. I believe the convergence of AI, biotechnology, and better biological data could accelerate drug discovery, make healthcare more personalized and affordable, and expand what is possible for diseases we struggle to prevent and treat today.
I’m particularly interested in the companies being built around that transition: the technologies enabling them, the clinical problems they are trying to solve, and the question of which ideas can translate from scientific or technical breakthroughs into products that meaningfully improve human health.
Through my projects and The Compound, I’m exploring that intersection—building tools, studying emerging research and companies, and translating complex ideas across medicine, biology, technology, and venture.
I care deeply about design. I want what I build to be useful, clear, and beautiful. But above all, I want it grounded in reality: real clinical workflows, real patient needs, and real problems worth solving.
My goal is to become someone who can move fluently between these worlds—understanding the medicine, engaging with the technology, recognizing what matters clinically, and helping turn promising ideas into better healthcare.
Writing
The Compound.
A Friday briefing on biology, emerging therapies and the companies behind them.